Inclusion and diversity in clinical trials: Actionable steps to drive lasting change
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Background: Improving diversity in clinical trials is essential in order to produce generalizable results. Although the importance of representation has become increasingly recognized, identifying strategies to approach this work remains elusive. This article reviews the proceedings of a multi-stakeholder conference about the current state of diversity in clinical trials and outlines actionable steps for improvement. Methods: Conference attendees included representatives from the United States Food and Drug Administration (FDA), National Institutes of Health (NIH), practicing clinical investigators, pharmaceutical and device companies, community-based organizations, data analytics companies, and patient advocacy groups. At this virtual event, attendees were asked to consider key questions around best practices for engagement of underrepresented populations. Results: Community engagement is an integral part of recruitment and retention of underrepresented groups. Decentralization of sites and use of digital tools can enhance the accessibility of clinical research. Finally, improving representation among investigators and clinical research staff may translate to diverse clinical trial participants. Conclusion: Improving diversity in clinical trials is an ethical and scientific imperative, which requires a multifaceted approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals
Flanagin, A., Frey, T., Christiansen, S. L., & AMA Manual of Style Committee (2021) · JAMA · doi:10.1001/jama.2021.13304 · Cited by 1,615
George, S., Duran, N., & Norris, K. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301706 · Cited by 1,603
EFFECTIVE RECRUITMENT AND RETENTION OF MINORITY RESEARCH PARTICIPANTS
Yancey, A. K., Ortega, A. N., & Kumanyika, S. K. (2006) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.27.021405.102113 · Cited by 1,196
Race, Ethnicity, and NIH Research Awards
Ginther, D. K., Schaffer, W. T., Schnell, J., Masimore, B., Liu, F., Haak, L. L., & Kington, R. (2011) · Science · doi:10.1126/science.1196783 · Cited by 1,075
A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops
Victor, R. G., Lynch, K., Li, N., Blyler, C., Muhammad, E., Handler, J., Brettler, J., Rashid, M., Hsu, B., Foxx-Drew, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1717250 · Cited by 559
Revisiting the Digital Divide in the COVID ‐19 Era
Lai, J., & Widmar, N. O. (2021) · Applied Economic Perspectives and Policy · doi:10.1002/aepp.13104 · Cited by 416
De Las Nueces, D., Hacker, K., DiGirolamo, A., & Hicks, L. S. (2012) · Health Services Research · doi:10.1111/j.1475-6773.2012.01386.x · Cited by 400
Heller, C., Balls-Berry, J. E., Nery, J. D., Erwin, P. J., Littleton, D., Kim, M., & Kuo, W. P. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.08.004 · Cited by 290
Unger, J. M., Hershman, D. L., Till, C., Minasian, L. M., Osarogiagbon, R. U., Fleury, M. E., & Vaidya, R. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa155 · Cited by 262
Lett, E., Orji, W. U., & Sebro, R. (2018) · PLOS ONE · doi:10.1371/journal.pone.0207274 · Cited by 260
Flores, L. E., Frontera, W. R., Andrasik, M. P., del Rio, C., Mondríguez-González, A., Price, S. A., Krantz, E. M., Pergam, S. A., & Silver, J. K. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37640 · Cited by 243
Price, J. H., Khubchandani, J., McKinney, M., & Braun, R. (2013) · BioMed Research International · doi:10.1155/2013/787616 · Cited by 195
A paradigm for understanding trust and mistrust in medical research: The Community VOICES study
Smirnoff, M., Wilets, I., Ragin, D. F., Adams, R., Holohan, J., Rhodes, R., Winkel, G., Ricci, E. M., Clesca, C., & Richardson, L. D. (2018) · AJOB Empirical Bioethics · doi:10.1080/23294515.2018.1432718 · Cited by 187
Barriers and facilitators to participation of minorities in clinical trials.
Schmotzer, G. L. (2012) · PubMed · Cited by 178
McFarlane, S. J., Occa, A., Peng, W., Awonuga, O., & Morgan, S. E. (2021) · Health Communication · doi:10.1080/10410236.2021.1943978 · Cited by 171
Sardar, M. R., Badri, M., Prince, C. T., Seltzer, J., & Kowey, P. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.4758 · Cited by 163
Decentralized Trials in the Age of Real‐World Evidence and Inclusivity in Clinical Investigations
Khozin, S., & Coravos, A. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1441 · Cited by 136
Andrasik, M. P., Broder, G. B., Wallace, S. E., Chaturvedi, R., Michael, N. L., Bock, S., Beyrer, C., Oseso, L. N., Aina, J., Lucas, J. P., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258858 · Cited by 117
Self-citationIntegrating Research into Community Practice — Toward Increased Diversity in Clinical Trials
Woodcock, J., Araojo, R., Thompson, T., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmp2107331 · Cited by 101
Thakur, N., Lovinsky‐Desir, S., Appell, D., Bime, C., Castro, L., Celedon, J. C., Ferreira, J. C., George, M., Mageto, Y. N., Mainous, A. G., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202105-1210st · Cited by 101
Burchard, E. G., Oh, S. S., Foreman, M. G., & Celedón, J. C. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1944pp · Cited by 100
Reza, N., Tahhan, A. S., Mahmud, N., DeFilippis, E. M., Alrohaibani, A., Vaduganathan, M., Greene, S. J., Ho, A., Fonarow, G. C., Butler, J., et al. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.006605 · Cited by 91
Using mobile technology to engage sexual and gender minorities in clinical research
Lunn, M. R., Capriotti, M. R., Flentje, A., Bibbins-Domingo, K. B., Pletcher, M. J., Triano, A. J., Sooksaman, C., Frazier, J., & Obedin‐Maliver, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216282 · Cited by 80
Henrietta Lacks: science must right a historical wrong
(2020) · Nature · doi:10.1038/d41586-020-02494-z · Cited by 78
Geographic Accessibility to Clinical Trials for Advanced Cancer in the United States
Galsky, M. D., Stensland, K. D., McBride, R. B., Latif, A., Moshier, E. L., Oh, W. K., & Wisnivesky, J. P. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.6300 · Cited by 74
Geographic distribution of clinical trials may lead to inequities in access
Seidler, E. M., Keshaviah, A. P., Brown, C. D., Wood, E. A., Granick, L., & Kimball, A. B. (2014) · Clinical Investigation · doi:10.4155/cli.14.21 · Cited by 65
Digital Literacy at an Urban Cancer Center: Implications for Technology Use and Vulnerable Patients
Leader, A. E., Capparella, L., Waldman, L. P., Cammy, R., Petok, A., Dean, R., Shimada, A., Yocavitch, L., Rising, K. L., Garber, G. D., et al. (2021) · JCO Clinical Cancer Informatics · doi:10.1200/cci.21.00039 · Cited by 45
Diversity and Inclusion in Pancreatic Cancer Clinical Trials
Herremans, K. M., Riner, A. N., Winn, R. A., & Trevino, J. G. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.079 · Cited by 45
Women’s Representation Among Lead Investigators of Clinical Trials in Oncology
Ludmir, E. B., Mainwaring, W., Miller, A. B., Lin, T. A., Jethanandani, A., Espinoza, A. F., & Holliday, E. B. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.2196 · Cited by 35
Health Literacy and Usability of Clinical Trial Search Engines
Utami, D., Bickmore, T., Barry, B. A., & Paasche‐Orlow, M. K. (2014) · Journal of Health Communication · doi:10.1080/10810730.2014.938842 · Cited by 17
Cited by
Mccradden, M., Odusi, O., Joshi, S., Akrout, I., Ndlovu, K., Glocker, B., Maicas, G., Liu, X., Mazwi, M., Garnett, T., et al. (2023) · 2023 ACM Conference on Fairness, Accountability, and Transparency · doi:10.1145/3593013.3594096 · Cited by 33
Metadata
- Authors
- Kelsey, M. D., Patrick-Lake, B., Abdulai, R., Broedl, U. C., Brown, A., Cohn, E., Curtis, L. H., Komelasky, C., Mbagwu, M., Mensah, G. A., Mentz, R. J., Nyaku, A., Omokaro, S. O., Sewards, J., Whitlock, K., Zhang, X., & Bloomfield, G. S.
- Venue
- Contemporary Clinical Trials
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 116
- Pages
- 106740
- ISSN
- 1551-7144 (ISSN-L)
- OpenAlex
- W4220841869
- Cited by
- 197
- References
- 31
- FWCI
- 29.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.